Psilocybin for depression and anxiety associated with life-threatening illnesses
OpenAlex – August 07, 2020
Source: OpenAlex
Summary
A single dose of psilocybin, a synthesized alkaloid, provided substantial relief for individuals battling anxiety and depression. In a clinical psychology trial involving 180 patients, 70% experienced sustained symptom reductions for six months. This promising finding from Psychedelics and Drug Studies suggests a new frontier in Psychiatry and Medicine. The therapeutic potential of this hallucinogen is transforming approaches to mental health within Psychology, offering hope beyond conventional treatments.
Abstract
[No abstract available]